Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/13/2012US8309794 Polyoleosins
11/13/2012US8309788 Protease inhibitors in absorbent articles
11/13/2012US8309697 Methods and compositions for the treatment and prevention of HIV infection using TRIM5α
11/13/2012US8309693 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/13/2012US8309687 Biomarker specific for cancer
11/13/2012US8309686 Neurotoxins with enhanced target specificity
11/13/2012US8309684 Synthetic analogues of neural regeneration peptides
11/13/2012US8309590 Triazol compounds for treating biofilm formation
11/13/2012US8309560 Methods and compositions for ameliorating the undesirable effects of chemotherapy
11/13/2012US8309535 Compositions and methods to treat recurrent medical conditions
11/13/2012US8309533 Allele-specific RNA interference
11/13/2012US8309527 For use as antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics
11/13/2012US8309525 Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
11/13/2012US8309524 Chimeric RGMa polypeptides
11/13/2012US8309523 Inhibitors of MALT1 proteolytic activity and uses thereof
11/13/2012US8309522 Neuromedin and FN-38 peptides for treating psychiatric diseases
11/13/2012US8309521 Spacer with a coating thereon for use with an implant device
11/13/2012US8309520 Fully synthetic albumin analog
11/13/2012US8309519 Compositions and methods for inhibiting vascular permeability
11/13/2012US8309518 Drug delivery matrices to enhance wound healing
11/13/2012US8309517 LGI, LINGO and p75NTR family members: novel modulators of neuronal growth
11/13/2012US8309515 Poly(ethylene oxide)-block-poly(ester) block copolymers
11/13/2012US8309514 Peptide nucleic acid based guanidinium compounds
11/13/2012US8309513 Approach to the treatment of compartment syndrome
11/13/2012US8309512 Platelet aggregation inhibitor composition
11/13/2012US8309355 Methods of treating Parkinson's disease using viral vectors
11/13/2012US8309350 Photoreactive regulator of protein function and methods of use thereof
11/13/2012US8309341 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
11/13/2012US8309320 Diagnosis of conditions associated with decreased arginine bioavailability
11/13/2012US8309312 Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
11/13/2012US8309123 Pharmaceutical compositions and methods for the oral delivery of insulin
11/13/2012US8309122 Oxymorphone controlled release formulations
11/13/2012US8309096 Fusion protein
11/13/2012US8309088 Method of treating osteoarthritis with an antibody to NGF
11/13/2012US8309087 Treatment with anti-ErbB2 antibodies
11/13/2012US8309081 Composition and method for treatment of bruising
11/13/2012US8309080 Metallo-protein and tocotrienol (MP-T3) compositions and uses thereof
11/13/2012US8309079 Use of fructanases in feed of hoofed animals, preferably to prevent diseases
11/13/2012US8309078 Method for conversion of uric acid to allantoin and related enzymes
11/13/2012US8309072 Irreversibly-inactivated pepsinogen fragments for modulating immune function
11/13/2012US8309069 Human serum albumin-free stabilized interferon liquid formulations
11/13/2012US8309068 Isolated polypeptides and methods of improving muscle strength
11/13/2012CA2641565C Nel-related proteins type 1 and 2, and polynucleotides encoding them
11/13/2012CA2615896C Macrocyclic peptides as hcv ns3 protease inhibitors
11/13/2012CA2549717C Compositions and methods for treating diabetes
11/13/2012CA2539467C Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide
11/13/2012CA2534314C Benzothiazole derivatives for the treatment of diabetes
11/13/2012CA2511294C Methods of treating neurological conditions with hematopoietic growth factors
11/13/2012CA2487061C Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
11/13/2012CA2478414C Selective targeting of tumor vasculature using antibody molecules
11/13/2012CA2451643C Antisense modulation of superoxide dismutase 1, soluble expression
11/13/2012CA2344993C Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus
11/13/2012CA2326692C Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
11/08/2012WO2012151578A1 Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists
11/08/2012WO2012151537A2 Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals
11/08/2012WO2012151517A1 Cochleate compositions and methods of making and using same
11/08/2012WO2012151476A1 Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
11/08/2012WO2012151406A1 Diagnosis and treatment of traumatic brain injury
11/08/2012WO2012151349A1 Neuroprotection by hepatic cells and hepatocyte secretory factors
11/08/2012WO2012151346A1 Expression signatures of genes and gene networks associated with skin aging
11/08/2012WO2012151317A1 Vascular disruption agents and uses thereof
11/08/2012WO2012151279A2 Induction of il-12 using immunotherapy
11/08/2012WO2012151266A1 Methods for handling biological drugs containing living cells
11/08/2012WO2012151195A1 Hepatitis c virus inhibitors
11/08/2012WO2012151159A1 Methods of modulating pla2g12a levels and treating disorders associated therewith
11/08/2012WO2012151051A1 Excipient compatibility with ezatiostat
11/08/2012WO2012150890A1 Antibacterial composition
11/08/2012WO2012150676A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
11/08/2012WO2012150663A1 Improved sugar-coated liposome composition
11/08/2012WO2012150495A1 Synthetic peptides and random copolymers for the treatment of autoimmune disorders
11/08/2012WO2012150254A1 Fgf based fibrin binding peptides
11/08/2012WO2012149653A1 Modulation of the sonic hedgehog pathway and uses thereof
11/08/2012WO2012149644A1 Novel agonists and antagonists of the urotensinergic system
11/08/2012WO2012129165A3 Novel antimicrobial activity of chicken nk-2 peptide against apicomplexan protozoa
11/08/2012WO2012125828A3 Methods of treating breast cancer with anthracycline therapy
11/08/2012WO2012125471A9 Methods and compositions relating to mesenchymal stem cell exosomes
11/08/2012WO2012125405A9 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
11/08/2012WO2012121971A3 Locally released growth factors to mediate motor recovery after stroke
11/08/2012WO2012120414A3 Edn3-like peptides and uses thereof
11/08/2012WO2012112438A3 Anti-microbial agents and compositions and methods of production and use thereof
11/08/2012WO2012103365A9 Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
11/08/2012WO2012088379A9 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
11/08/2012WO2012047354A4 Environmentally sensitive compositions
11/08/2012WO2012001647A3 C10rf32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders
11/08/2012US20120283620 Treatment utilizing hydrophobic weak bases chemotherapeutic agents and illumination
11/08/2012US20120283421 Methods and reagents for decreasing clinical reaction to allergy
11/08/2012US20120283312 Modulation of eif4e expression
11/08/2012US20120283205 Compositions and methods of delivery of pharmacological agents
11/08/2012US20120283196 Beta-hairpin peptidomimetics
11/08/2012US20120283195 Glycopeptide phosphonate derivatives
11/08/2012US20120283194 Inhibitors of Atypical Protein Kinase C and Their Use in Treating Hedgehog Pathway-Dependent Cancers
11/08/2012US20120283193 Manipulation of brain in a circuit-specific manner
11/08/2012US20120283192 Method of treating conditions associated with airway tissue remodeling
11/08/2012US20120283191 Approach To Treat Intraocular Hypertension
11/08/2012US20120283190 Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis
11/08/2012US20120283189 Na-k pump modulation
11/08/2012US20120283188 Genes and proteins associated with angiogenesis and uses thereof
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120283186 Therapeutic agent delivery apparatus and process
11/08/2012US20120283185 Food composition and method of using same
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 3163